METTL14-dependent m6A modification restrains interferon signaling to prevent myocarditis and dilated Cardiomyopathy

Cardiomyocyte-specific deletion of the m6A methyltransferase METTL14 triggers myocarditis and dilated cardiomyopathy by disrupting mitochondrial integrity and autophagy, which leads to RIPK1 accumulation, hyperactivation of type I interferon signaling, and necroptosis.

The Gist

The Big Picture: A Heart Under Siege

Imagine your heart is a busy, high-tech power plant. Its job is to pump energy (blood) to the whole city (your body). Usually, this power plant has a very strict security system to keep things running smoothly and to stop the "fire alarms" (immune responses) from going off when there is no fire.

This paper discovers a specific security guard named METTL14. When this guard is fired (deleted from the heart cells), the power plant goes into chaos. The heart starts attacking itself, leading to a condition called myocarditis (heart inflammation) and eventually dilated cardiomyopathy (a weak, stretched-out heart that can't pump well).

The Secret Code: The "Post-it Note" System

To understand how METTL14 works, we need to talk about m6A.

Think of your heart cells as a library full of instruction manuals (RNA) that tell the cell how to build proteins and function.

• METTL14 is a librarian who writes Post-it notes (m6A modifications) on these manuals.
• These notes usually say things like, "Don't read this too much," or "Recycle this manual quickly."
• In a healthy heart, METTL14 puts these notes on specific manuals that control the immune system, keeping them quiet so the heart doesn't get confused and think it's under attack.

What Happens When the Guard is Gone?

The researchers created mice that lacked METTL14 in their heart cells. Without the librarian to put the "calm down" Post-it notes on the manuals, the instructions for the immune system went wild.

1. The False Alarm: Without the notes, the cell starts reading the "Emergency!" manuals over and over again. It thinks there is a virus or an invader, even though there isn't one.
2. The Alarm Sirens (Interferon): The cell sounds the "Type I Interferon" alarm. This is a powerful signal meant to fight viruses, but in this case, it's a false alarm. It tells the heart cells, "We are under attack! Prepare for war!"
3. The Self-Destruct Button (Necroptosis): Because the alarm is so loud, the heart cells start a process called necroptosis. This is a specific type of "suicide" where the cell explodes to release its contents, which triggers even more inflammation. It's like a worker in the power plant blowing up a wall to stop a fake intruder, causing a massive fire.

The Chain Reaction: From Bad Notes to a Broken Heart

The paper maps out exactly how this chain reaction happens:

• Step 1: The Trash Can Breaks. Without METTL14, the heart's "trash can" (autophagy/mitophagy) stops working. The cell can't clean up its broken mitochondria (the tiny batteries inside the cell).
• Step 2: The Leaking Battery. These broken batteries leak their contents into the cell's main room. The cell's security sensors (cGAS-STING) see this leak and scream, "INTRUDER!"
• Step 3: The Alarm Blares. This triggers the Interferon signal.
• Step 4: The Explosion. The Interferon signal tells the cell to activate RIPK1, a protein that acts like a detonator. This causes the heart cells to die via necroptosis.
• The Result: The heart muscle gets inflamed, scarred, and stretched out (dilated). The heart becomes weak and eventually stops working, leading to early death in the mice.

The "Magic Fix": Turning Off the Alarm

The most exciting part of the study is what happened when the researchers tried to fix the problem.

They took the mice with the broken heart (no METTL14) and also removed the receiver for the alarm signal (the IFNAR1 receptor).

• Analogy: Imagine the heart is screaming "Fire!" (Interferon), but you cut the wires to the fire department's radio (IFNAR1). The fire department never hears the call, so they don't send the trucks that cause the damage.
• The Result: Even though the heart still had broken batteries and no METTL14, the heart cells didn't explode. The mice lived much longer, their hearts stayed strong, and the inflammation disappeared.

Why This Matters

This discovery is huge for two reasons:

1. It explains a mystery: It tells us why some hearts fail due to inflammation even when there is no virus. The heart's own "Post-it note" system (METTL14) failed, causing it to attack itself.
2. It offers a new treatment path: It suggests that for people with inflammatory heart failure (like those who get heart issues from cancer immunotherapy drugs or autoimmune diseases), we might not need to fix the heart muscle directly. Instead, we could try to turn down the volume on the immune alarm (blocking Interferon or RIPK1) to stop the heart from destroying itself.

In short: METTL14 is the heart's "quiet mode" button. When it breaks, the heart thinks it's under attack, panics, and destroys itself. If we can mute that panic signal, the heart can survive.

Technical Summary

1. Problem Statement

Heart failure is a global health crisis often driven by inflammation, yet the specific mechanisms by which cardiomyocytes intrinsically restrain innate immune activation remain poorly understood. While Type I Interferon (IFN-I) signaling is known to drive cardiac injury in viral myocarditis and immune checkpoint inhibitor (ICI)-induced cardiotoxicity, the upstream epitranscriptomic regulators that prevent aberrant IFN-I activation in healthy cardiomyocytes are unknown. Additionally, the role of N⁶-methyladenosine (m⁶A) RNA modification in maintaining cardiac immune homeostasis and preventing necroptotic cell death has not been fully elucidated.

2. Methodology

The study employed a multi-faceted approach combining genetic mouse models, multi-omics sequencing, and physiological assessments:

• Genetic Models:
  • Knockout (KO): Generated cardiomyocyte-specific Mettl14 knockout mice (cmMettl14-/-) using MLC2v-KICre crossed with floxed Mettl14 mice.
  • Overexpression (OE): Generated cardiomyocyte-specific Mettl14 overexpression mice.
  • Rescue Model: Crossed cmMettl14-/- mice with Ifnar1-/- (IFN-I receptor knockout) mice to create double-knockout mice.
• Physiological & Histological Analysis:
  • Echocardiography: Serial assessment of Left Ventricular Ejection Fraction (LVEF), dimensions (LVID), and wall thickness.
  • Histology: H&E staining for inflammation, Masson's trichrome for fibrosis, and Transmission Electron Microscopy (TEM) for ultrastructural analysis (mitochondria and myofibrils).
  • Stress Testing: Transverse Aortic Constriction (TAC) to assess adaptive hypertrophic responses.
• Molecular & Omics:
  • MeRIP-seq & RNA-seq: Parallel sequencing to identify m⁶A peaks and transcriptomic changes in cmMettl14-/- hearts.
  • Western Blotting: Analysis of m⁶A levels, immune signaling proteins (STING, IRF3, STAT1), autophagy markers (LC3B, p62), and cell death markers (RIPK1, HMGB1, Caspase-8, PARP).
  • qRT-PCR: Validation of Interferon-Stimulated Genes (ISGs).

3. Key Contributions

• Discovery of a Critical Checkpoint: Identified METTL14-mediated m⁶A modification as a vital intrinsic "brake" that prevents spontaneous activation of innate immunity in cardiomyocytes.
• Mechanistic Link: Established a direct causal link between m⁶A hypomethylation, mitochondrial dysfunction, cGAS-STING pathway activation, and lethal IFN-I signaling.
• Cell Death Pathway Specificity: Demonstrated that METTL14 loss shifts cardiomyocyte cell death from apoptosis/pyroptosis toward RIPK1-dependent necroptosis.
• Therapeutic Insight: Showed that genetic ablation of the IFN-I receptor (Ifnar1) rescues the lethal phenotype, suggesting that targeting the IFN-I axis could treat inflammatory cardiomyopathies.

4. Key Results

A. Phenotypic Consequences of METTL14 Loss

• Lethality & Cardiomyopathy: cmMettl14-/- mice exhibited early lethality (100% mortality by 7 months) characterized by spontaneous myocarditis, severe dilated cardiomyopathy (DCM), reduced LVEF, and ventricular dilation.
• Histology: Hearts showed inflammatory infiltration, myocyte disarray, interstitial fibrosis, and severe ultrastructural defects including swollen mitochondria with disrupted cristae and myofibrillar dissolution.
• Hypertrophy Failure: Unlike controls, cmMettl14-/- hearts failed to undergo adaptive concentric hypertrophy in response to TAC pressure overload, instead undergoing pathological dilation and systolic dysfunction.
• Gain-of-Function: Conversely, Mettl14 overexpression enhanced contractile function and promoted concentric hypertrophy.

B. Transcriptomic and Epitranscriptomic Mechanisms

• Hypomethylation & Upregulation: MeRIP-seq revealed widespread global m⁶A hypomethylation in cmMettl14-/- hearts. Crucially, 51% of upregulated genes were hypomethylated, indicating that m⁶A normally acts as a destabilizing mark for these transcripts.
• Innate Immune Activation: The hypomethylated/upregulated genes were heavily enriched for innate immune pathways, specifically the cGAS-STING axis and IFN-I signaling.
• Specific Targets: RIPK1 (a key necroptosis regulator) and IRGM1 (involved in mitochondrial quality control) were identified as hypomethylated and upregulated targets.

C. The cGAS-STING-IFN-I-Necroptosis Axis

• Mitochondrial Origin: METTL14 loss impaired autophagy/mitophagy (reduced LC3B-II, altered p62), leading to mitochondrial dysfunction and cytosolic mtDNA leakage.
• Pathway Activation: Cytosolic mtDNA activated the cGAS-STING pathway, resulting in elevated IRF3, STING, and robust IFN-I production.
• Necroptosis: The study found that METTL14 loss suppressed apoptosis (reduced cleaved PARP) and pyroptosis but promoted necroptosis. This was evidenced by:
  • Upregulation of RIPK1 and HMGB1 (a DAMP released during necroptosis).
  • Reduction of Caspase-8 (which normally cleaves RIPK1 to prevent necroptosis).
• IFN-I Dependence: The upregulation of RIPK1 and HMGB1 was dependent on IFN-I signaling.

D. Rescue by IFN-I Receptor Ablation

• Survival & Function: Crossing cmMettl14-/- with Ifnar1-/- mice significantly rescued survival rates (>75% alive vs. 0% in single KO) and restored LVEF and ventricular dimensions.
• Structural Rescue: TEM analysis showed that Ifnar1 deletion restored mitochondrial morphology and myofibril organization in the double-knockout hearts.
• Molecular Rescue: Ifnar1 deletion normalized STAT1 phosphorylation and suppressed RIPK1/HMGB1 upregulation, confirming that IFN-I signaling drives the necroptotic injury. Notably, Ifnar1 deletion did not restore the underlying autophagy/mitophagy defects, placing mitochondrial dysfunction upstream of the IFN-I signal.

5. Significance

This study redefines the role of m⁶A modification in the heart, moving beyond metabolic regulation to immune homeostasis.

• Novel Pathogenesis: It establishes a "METTL14–m⁶A–Mitochondria–IFN-I–Necroptosis" axis as a central driver of inflammatory heart failure.
• Clinical Relevance: The findings provide a mechanistic explanation for the cardiac toxicity seen in viral myocarditis and ICI-induced myocarditis, where IFN-I signaling is hyperactive.
• Therapeutic Potential: The rescue of the lethal phenotype by Ifnar1 deletion suggests that blocking IFN-I signaling or necroptosis (RIPK1 inhibition) could be effective therapeutic strategies for patients with inflammatory cardiomyopathies, particularly those with underlying epitranscriptomic dysregulation.

In summary, METTL14 acts as a guardian of cardiomyocyte survival by ensuring the m⁶A-mediated degradation of transcripts that would otherwise trigger a lethal cycle of mitochondrial stress, innate immune activation, and necroptotic cell death.